Narcan (naloxone hydrochloride) NDC 50090-2422

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-2422Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-2422Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-2422-0	50090242200	2 VIAL, SINGLE-DOSE in 1 PACKAGE (50090-2422-0) / .1 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 24, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Narcan
Generic name (nonproprietary): naloxone hydrochloride
Active ingredients: Naloxone hydrochloride — 4 mg/.1mL
Dosage form: Spray
Route: Nasal
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 208411
Marketing start: Jan 24, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Opioid Antagonists (Mechanism)
Identifiers: Product ID 50090-2422_caf3eabb-89bd-469a-9d00-3fd3a18fb5dbSPL ID caf3eabb-89bd-469a-9d00-3fd3a18fb5dbSPL set ID 139c30b9-5600-48f5-8610-0cacd2782398RxCUI 1725059, 1725064UNII F850569PQR
Pharmacologic class: Opioid Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090242200 followed by a unit qualifier and the quantity

Package 50090-2422-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 28, 2023.

Indications (excerpt from the label)

NARCAN Nasal Spray is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. NARCAN Nasal Spray is intended for immediate administration as emergency therapy in settings where opioids may be present. NARCAN Nasal Spray is not a substitute for emergency medical care. NARCAN Nasal Spray is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. ( 1 ) NARCAN Nasal Spray is intended for immediate administration as emergency therapy in settings where opioids may be present. ( 1 ) NARCAN Nasal S…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 208411

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 208411
Product	Strength	Form · route	Labeler	Product NDC
Narcannaloxone hydrochloride	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	Emergent Devices Inc.	69547-353
Narcannaloxone hydrochloride nasal	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	Emergent Devices Inc.	69547-627
Naloxone Hydrochloridenaloxone hydrochloride nasal	Naloxone hydrochloride 4 mg/.1mL	InhalantNasal	A-S Medication Solutions	50090-5908
Narcan Naloxone Hci	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	HF Acquisition Co LLC, DBA HealthFirst	51662-1240
Narcannaloxone hydrochloride nasal	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	Sportpharm LLC	85766-076
Narcan Naloxone HCL	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	HF Acquisition Co LLC, DBA HealthFirst	51662-1642
Narcannaloxone hydrochloride	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	Proficient Rx LP	71205-528